Alector

ALECNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$197.625 M

$1.78 -2.73%

Close of 7 Aug 2026

Revenue

$21.0M

#2984 by revenue

Earnings

-$143.0M

Loss-making

Shares outstanding

111,656,919

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#94InvivydIVVD$218.0M
#95Protalix BioTherapeuticsPLX$198.2M
#96AlectorALEC$197.6M
#97Voyager TherapeuticsVYGR$197.6M
#98Coherus OncologyCHRS$196.2M

Where these numbers come from

Share counts and financials for Alector are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.